AtlasBase Introduces High‑Capacity DNA Capsules Aiming at Petabyte‑Level Archival Storage

AtlasBase revealed a prototype DNA‑based storage cartridge capable of eventually storing as much as 50 petabytes of information within a single capsule, framing the solution as a potential replacement for magnetic tape in long‑term archiving. The cartridge is intended to house 100 such capsules, yielding a capacity spectrum that currently starts at 100 terabytes and could reach up to five exabytes once the complete roadmap is realized.

AtlasBase emphasized the natural resilience of DNA, pointing out that encoded genetic strands can stay stable for over a thousand years without requiring power, refrigeration, or special environmental management. Such endurance starkly differs from conventional tape media, which deteriorates over a few decades and demands climate‑controlled storage facilities.

Although the capacity forecasts are bold, AtlasBase has yet to reveal performance figures like read/write speeds, nor have they shared pricing details or a schedule for market launch. Analysts warn that absent transparency on throughput and expense, the technology could stay confined to a niche role for ultra‑long‑term preservation instead of becoming a widespread substitute for current archival processes.

For years, multiple research teams have investigated DNA storage, taking advantage of the molecule’s exceptional data density and durability. The method generally consists of synthesizing DNA strands that encode binary data, preserving them, and later sequencing the strands to read the stored information. Yet, both synthesis and sequencing have traditionally been costly and slow, limiting the technology’s uptake on a large scale.

According to AtlasBase’s roadmap, progress in enzymatic synthesis and high‑throughput sequencing may eventually reduce both expense and latency, rendering petabyte‑class capsules practical for organizations that must protect vast data collections for centuries. Upcoming milestones are slated to concentrate on expanding manufacturing, enhancing error‑correction techniques, and embedding the capsules within current data‑center architectures. Until these challenges are resolved, the sector will monitor closely to determine if DNA can transition from a laboratory novelty to a viable archival medium.